Inventor
GUDKOV ANDREI
US43 patents
⚠️ This page may combine multiple inventors who share the name “GUDKOV ANDREI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV ILLINOIS
18 patentsUS5811234ASep 22, 1998
Methods and applications for efficient genetic suppressor elements
UNIV ILLINOIS107 citations96
US5665550ASep 9, 1997
Genes and genetic elements associated with sensitivity to chemotherapeutic drugs
UNIV ILLINOIS34 citations92
US5942389AAug 24, 1999
Genes and genetic elements associated with sensitivity to cisplatin
UNIV ILLINOIS16 citations79
US5866327AFeb 2, 1999
Association of kinensin with sensitivity to chemotherapeutic drugs
UNIV ILLINOIS6 citations74
US6197521B1Mar 6, 2001
Genes and genetic elements associated with control of neoplastic transformation in mammalian cells
UNIV ILLINOIS5 citations71
US6083745AJul 4, 2000
Genes and genetic elements associated with control of neoplastic transformation in mammalian cells
UNIV ILLINOIS8 citations71
US6083746AJul 4, 2000
Genes and genetic elements associated with control of neoplastic transformation in mammalian cells
UNIV ILLINOIS7 citations71
US5753432AMay 19, 1998
Genes and genetic elements associated with control of neoplastic transformation in mammalian cells
UNIV ILLINOIS7 citations71
US6297366B1Oct 2, 2001
ING-encoded p33ING1 protein as a mediator of p53 signaling pathway in mammalian cells
UNIV ILLINOIS9 citations68
US6861431B2Mar 1, 2005
Compounds capable of modulating the activity of multidrug transporters and therapeutic use of the same
UNIV ILLINOIS11 citations66
US6537754B1Mar 25, 2003
Association of kinesin with sensitivity to chemotherapeutic drugs
UNIV ILLINOIS3 citations63
US6326488B1Dec 4, 2001
Gene and genetic elements associated with sensitivity to chemotherapeutic drugs
UNIV ILLINOIS4 citations63
US6060244AMay 9, 2000
Genes and genetic elements associated with sensitivity to chemotherapeutic drugs
UNIV ILLINOIS5 citations63
US6043340AMar 28, 2000
Association of kinesin with sensitivity to chemotherapeutic drugs
UNIV ILLINOIS4 citations63
US6376241B1Apr 23, 2002
Methods and applications for efficient genetic suppressor elements
UNIV ILLINOIS1 citations61
US6281011B1Aug 28, 2001
Methods and applications for efficient genetic suppressor elements
UNIV ILLINOIS4 citations61
US6541603B1Apr 1, 2003
Genes and genetic elements associated with sensitivity to platinum-based drugs
UNIV ILLINOIS3 citations60
US6982313B2Jan 3, 2006
Genes and genetic elements associated with sensitivity to chemotherapeutic drugs
UNIV ILLINOIS1 citations52
CLEVELAND BIOLABS INC
5 patentsUS9006180B2Apr 14, 2015
Methods for treating tourniquet-induced injuries
CLEVELAND BIOLABS INC5 citations83
US10034926B2Jul 31, 2018
Use of toll-like receptor agonist for treating cancer
CLEVELAND BIOLABS INC5 citations81
US11628201B2Apr 18, 2023
Use of toll-like receptor agonist for treating cancer
CLEVELAND BIOLABS INC0 citations59
US10780152B2Sep 22, 2020
Use of toll-like receptor agonist for treating cancer
CLEVELAND BIOLABS INC0 citations49
US10265390B2Apr 23, 2019
Use of toll-like receptor agonist for treating cancer
CLEVELAND BIOLABS INC0 citations49
GUDKOV ANDREI
4 patentsUS8324163B2Dec 4, 2012
Methods for treating reperfusion injuries using flagellin
GUDKOV ANDREI24 citations91
US8618059B2Dec 31, 2013
Methods for treating reperfusion injuries using flagellin
GUDKOV ANDREI7 citations82
US8486697B2Jul 16, 2013
Inducing cell death by inhibiting adaptive heat shock response
GUDKOV ANDREI2 citations54
US8318724B2Nov 27, 2012
Small molecule inhibitors of MRP1 and other multidrug transporters
GUDKOV ANDREI0 citations40
INCURON LLC
4 patentsUS9566265B2Feb 14, 2017
Carbazole compounds and therapeutic uses of the compounds
INCURON LLC2 citations68
US9169207B2Oct 27, 2015
Curaxins for use in treating carcinogen-induced cancer
INCURON LLC3 citations60
US9108916B2Aug 18, 2015
Carbazole compounds and therapeutic uses of the compounds
INCURON LLC2 citations58
US10137109B2Nov 27, 2018
Carbazole compounds and therapeutic uses of the compounds
INCURON LLC0 citations48
UNIV TECHNOLOGIES INT
3 patentsUS6420136B1Jul 16, 2002
Method of modulating p53 activity
UNIV TECHNOLOGIES INT30 citations90
US6117633ASep 12, 2000
DNA sequence encoding the tumor suppressor gene ING1
UNIV TECHNOLOGIES INT12 citations72
US6037121AMar 14, 2000
DNA sequence encoding a tumor suppressor gene
UNIV TECHNOLOGIES INT1 citations51
CLEVELAND CLINIC FOUNDATION
3 patentsUS8008260B2Aug 30, 2011
Methods of protecting against apoptosis using lipopeptides
CLEVELAND CLINIC FOUNDATION5 citations71
US9006183B2Apr 14, 2015
Methods of protecting against apoptosis using lipopeptides
CLEVELAND CLINIC FOUNDATION1 citations60
US9381225B2Jul 5, 2016
Methods of protecting against apoptosis using lipopeptides
CLEVELAND CLINIC FOUNDATION0 citations50